PSA Velocity: What the Rate of PSA Rise Actually Means

PSA velocity is the average change in PSA per year. It sounds as if it should be a sharper warning sign than a single reading, and researchers have tested that idea for more than thirty years. The honest summary is that the evidence is mixed and narrower than most websites suggest, and no single cut-off is agreed. This guide explains how velocity is calculated, where the popular '0.75 ng/mL per year' figure comes from, what later studies found, and what to do with a rising PSA.

What PSA Velocity Is and How to Calculate It

The basic formula is the change in PSA divided by the time between tests in years: (PSA 2 − PSA 1) ÷ years. For example, a PSA of 2.1 ng/mL in January 2025 and 3.0 ng/mL in January 2026 gives (3.0 − 2.1) ÷ 1 = 0.9 ng/mL per year. With only two results this is a crude average of the change between them.

A 2012 review by Vickers and Brewster found that calculating PSA velocity and doubling time is 'far from straightforward': more than 20 different methods have been proposed, and many give divergent results [2]. Two clinicians can therefore reach different velocities from the same set of results, which is one reason any single threshold deserves caution.

Where the 0.75 ng/mL per Year Figure Comes From

The figure most often repeated online traces to a 1992 study of 54 men (16 with no prostate disease, 20 with benign prostatic hyperplasia and 18 with prostate cancer) whose stored blood samples were measured 7 to 25 years before diagnosis. About five years before diagnosis, PSA was rising by 0.75 µg/L per year (the same unit as ng/mL) in the men who later had cancer. That was significantly faster than in the BPH and control groups, and the rate of change separated the groups with a specificity of 90% and 100% [1].

That was a promising early finding from a small group, and the authors suggested rate of change might be an early marker of prostate cancer [1]. It was never a validated screening rule, and it was measured in men whose outcome was already known.

What Later Research Found

Later studies looked at velocity as a marker of risk, with different results and different thresholds:

• •A 2006 analysis of 980 men in the Baltimore Longitudinal Study of Aging (856 without prostate cancer, 104 with prostate cancer who were alive or died of other causes, and 20 who died of prostate cancer) found that velocity measured 10 to 15 years before diagnosis, when most men had a PSA below 4.0 ng/mL, was associated with cancer-specific survival 25 years later. Survival was 92% for men with a velocity of 0.35 ng/mL per year or less and 54% above that (95% confidence interval 15% to 82%), a relative risk of death of 4.7 (95% CI 1.3 to 16.5) [3]. The threshold was 0.35, not 0.75, and with only 20 cancer deaths the estimates are wide.
• •In 1,095 men with localized prostate cancer treated with radical prostatectomy, a PSA rise of more than 2.0 ng/mL in the year before diagnosis was associated with a significantly shorter time to death from prostate cancer than a rise of 2.0 or less [4].
• •In 358 men treated with radiation, a rise of more than 2.0 ng/mL in the year before diagnosis was associated with a higher risk of death from prostate cancer (adjusted hazard ratio 12.0, 95% CI 3.0 to 54.0). Among men with low-risk disease, the estimated seven-year prostate cancer mortality was 19% with a rise above 2.0 versus 0% for those at or below it [5].

The last two studies were in men who had already been diagnosed and treated. They say something about risk after diagnosis, not about whether velocity can find cancer in a man who has not been diagnosed. On that second question, the 2012 review concluded that PSA velocity and doubling time have no role in diagnosing prostate cancer, or in judging prognosis, for men before treatment. It described them as critical for understanding prognosis in advanced or relapsed disease [2].

Putting these together: three different cut-offs (0.35, 0.75 and 2.0 ng/mL per year) come from studies of different men and designs, and none of them establishes a universal threshold for a man who has not been diagnosed.

Why a Single Rise Can Mislead

PSA is made by prostate tissue, healthy or not. A review of PSA's limitations lists enlarged prostate volume with ageing, urinary retention, acute and chronic prostate inflammation, sexual activity and digital rectal examination as all able to raise it [6]. Some specifics:

• •Ejaculation: in a study of 64 men aged 49 to 79, PSA rose after ejaculation in 87%, by a mean of 41% at one hour. 92% were back to baseline by 24 hours and 97% by 48 hours, and the authors recommended abstaining for 48 hours before a PSA test [7].
• •Cycling: a study of 260 riders in a four-day, 250-mile race found no statistically or clinically significant PSA increase. The four men who started with a PSA above 4.0 ng/mL did show a larger change (1.65 ng/mL), though the authors said this did not represent the population [8]. A second study of 33 men aged 50 to 74 on a 13-mile ride found no significant change in total PSA [9].
• •Finasteride and dutasteride lower serum PSA by close to 50% [6]. In the Prostate Cancer Prevention Trial, the adjustment factor needed to restore the median PSA rose from 2 at 24 months to 2.5 at seven years of finasteride [10]. Starting or stopping one of these drugs between two tests will distort any velocity calculation.

What to Do With a Rising PSA

A rising PSA is a reason to talk to your doctor, and a flat one is not a guarantee. Some practical steps:

• •Write down every result with its date and the laboratory that reported it.
• •Note anything that could affect a particular result: recent ejaculation, an infection or urinary symptoms, a recent rectal exam or prostate procedure, and any medicines, especially finasteride or dutasteride.
• •Ask whether a repeat test makes sense before any bigger step is taken.
• •Ask whether further testing, such as free PSA or an MRI, would help, and whether you should see a urologist.

For men who have already been diagnosed or treated, PSA changes are used differently. See our guide to PSA velocity and doubling time.

Supplements do not change what a PSA trend means, and none of the products below is a PSA treatment or a substitute for testing. If you take any supplement, tell your doctor.